Cystathionine beta-synthase mutations: effect of mutation topology on folding and activity
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
Grantová podpora
Wellcome Trust - United Kingdom
070255/Z/03/Z
Wellcome Trust - United Kingdom
PubMed
20506325
PubMed Central
PMC2966864
DOI
10.1002/humu.21273
Knihovny.cz E-zdroje
- MeSH
- cystathionin-beta-synthasa chemie nedostatek genetika MeSH
- Escherichia coli genetika MeSH
- homocystinurie enzymologie genetika MeSH
- katalytická doména genetika MeSH
- katalýza MeSH
- kvarterní struktura proteinů MeSH
- lidé MeSH
- molekulární modely MeSH
- multimerizace proteinu MeSH
- mutace * MeSH
- mutantní proteiny chemie genetika metabolismus MeSH
- nízká teplota MeSH
- rozpustnost MeSH
- sbalování proteinů MeSH
- stabilita enzymů MeSH
- terciární struktura proteinů MeSH
- western blotting MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- Názvy látek
- cystathionin-beta-synthasa MeSH
- mutantní proteiny MeSH
Misfolding of mutant enzymes may play an important role in the pathogenesis of cystathionine beta-synthase (CBS) deficiency. We examined properties of a series of 27 mutant variants, which together represent 70% of known alleles observed in patients with homocystinuria due to CBS deficiency. The median amount of SDS-soluble mutant CBS polypeptides in the pellet after centrifugation of bacterial extracts was increased by 50% compared to the wild type. Moreover, mutants formed on average only 12% of tetramers and their median activity reached only 3% of the wild-type enzyme. In contrast to the wild-type CBS about half of mutants were not activated by S-adenosylmethionine. Expression at 18 degrees C substantially increased the activity of five mutants in parallel with increasing the amounts of tetramers. We further analyzed the role of solvent accessibility of mutants as a determinant of their folding and activity. Buried mutations formed on average less tetramers and exhibited 23 times lower activity than the solvent exposed mutations. In summary, our results show that topology of mutations predicts in part the behavior of mutant CBS, and that misfolding may be an important and frequent pathogenic mechanism in CBS deficiency.
Zobrazit více v PubMed
Carra S, Sivilotti M, Chavez Zobel AT, Lambert H, Landry J. HspB8, a small heat shock protein mutated in human neuromuscular disorders, has in vivo chaperone activity in cultured cells. Hum Mol Genet. 2005;14:1659–1669. PubMed
Chen S, Ito M, Saijo T, Naito E, Kuroda Y. Molecular genetic analysis of pyridoxine-nonresponsive homocystinuric siblings with different blood methionine levels during the neonatal period. J Med Invest. 1999;46:186–191. PubMed
Chen X, Wang L, Fazlieva R, Kruger WD. Contrasting behaviors of mutant cystathionine β-synthase enzymes associated with pyridoxine response. Hum Mutat. 2006;27:474–482. PubMed
Dawson PA, Cox AJ, Emmerson BT, Dudman NP, Kraus JP, Gordon RB. Characterisation of five missense mutations in the cystathionine β-synthase gene from three patients with B6-nonresponsive homocystinuria. Eur J Hum Genet. 1997;5:15–21. PubMed
de Franchis R, Kozich V, McInnes RR, Kraus JP. Identical genotypes in siblings with different homocystinuric phenotypes: identification of three mutations in cystathionine β-synthase using an improved bacterial expression system. Hum Mol Genet. 1994;3:1103–1108. PubMed
de Franchis R, Kraus E, Kozich V, Sebastio G, Kraus JP. Four novel mutations in the cystathionine β-synthase gene: effect of a second linked mutation on the severity of the homocystinuric phenotype. Hum Mutat. 1999;13:453–457. PubMed
Evande R, Blom H, Boers GH, Banerjee R. Alleviation of intrasteric inhibition by the pathogenic activation domain mutation, D444N, in human cystathionine β-synthase. Biochemistry. 2002;41:11832–11837. PubMed
Ferguson KA. Starch-gel electrophoresis—application to the classification of pituitary proteins and polypeptides. Metabolism. 1964;13(Suppl):985–1002. PubMed
Gaustadnes M, Ingerslev J, Rutiger N. Prevalence of congenital homocystinuria in Denmark. N Engl J Med. 1999;340:1513. PubMed
Gaustadnes M, Wilcken B, Oliveriusova J, McGill J, Fletcher J, Kraus JP, Wilcken DE. The molecular basis of cystathionine β-synthase deficiency in Australian patients: genotype–phenotype correlations and response to treatment. Hum Mutat. 2002;20:117–126. PubMed
Gordon RB, Cox AJ, Dawson PA, Emmerson BT, Kraus JP, Dudman NP. Mutational analysis of the cystathionine β-synthase gene: a splicing mutation, two missense mutations and an insertion in patients with homocystinuria. Mutations in brief no. 120. Online. Hum Mutat. 1998;11:332. PubMed
Gupta S, Wang L, Hua X, Krijt J, Kozich V, Kruger WD. Cystathionine β-synthase p.S466L mutation causes hyperhomocysteinemia in mice. Hum Mutat. 2008;29:1048–1054. PubMed PMC
Hedrick JL, Smith AJ. Size and charge isomer separation and estimation of molecular weights of proteins by disc gel electrophoresis. Arch Biochem Biophys. 1968;126:155–164. PubMed
Heil SG, Riksen NP, Boers GH, Smulders Y, Blom HJ. DNA methylation status is not impaired in treated cystathionine β-synthase (CBS) deficient patients. Mol Genet Metab. 2007;91:55–60. PubMed
Hu FL, Gu Z, Kozich V, Kraus JP, Ramesh V, Shih VE. Molecular basis of cystathionine β-synthase deficiency in pyridoxine responsive and nonresponsive homocystinuria. Hum Mol Genet. 1993;2:1857–1860. PubMed
Janosik M, Kery V, Gaustadnes M, Maclean KN, Kraus JP. Regulation of human cystathionine β-synthase by S-adenosyl-L-methionine: evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region. Biochemistry. 2001a;40:10625–10633. PubMed
Janosik M, Oliveriusova J, Janosikova B, Sokolova J, Kraus E, Kraus JP, Kozich V. Impaired heme binding and aggregation of mutant cystathionine β-synthase subunits in homocystinuria. Am J Hum Genet. 2001b;68:1506–1513. PubMed PMC
Janosik M, Sokolova J, Janosikova B, Krijt J, Klatovska V, Kozich V. Birth prevalence of homocystinuria in Central Europe: frequency and pathogenicity of mutation c.1105C T (p.R369C) in the cystathionine β-synthase gene. J Pediatr. 2009;154:431–437. PubMed PMC
Katsushima F, Oliveriusova J, Sakamoto O, Ohura T, Kondo Y, Iinuma K, Kraus E, Stouracova R, Kraus JP. Expression study of mutant cystathionine β-synthase found in Japanese patients with homocystinuria. Mol Genet Metab. 2006;87:323–328. PubMed
Kim CE, Gallagher PM, Guttormsen AB, Refsum H, Ueland PM, Ose L, Folling I, Whitehead AS, Tsai MY, Kruger WD. Functional modeling of vitamin responsiveness in yeast: a common pyridoxine-responsive cystathionine β-synthase mutation in homocystinuria. Hum Mol Genet. 1997;6:2213–2221. PubMed
Kluijtmans LA, Boers GH, Kraus JP, van den Heuvel LP, Cruysberg JR, Trijbels FJ, Blom H. The molecular basis of homocystinuria due to cystathionine β-synthase deficiency in Dutch homocystinuria patients. Effect of CBS genotype on biochemical and clinical phenotype, and on response upon treatment. The Netherlands: University of Nijmegen; 1998. PhD thesis. PubMed PMC
Kluijtmans LA, Boers GH, Kraus JP, van den Heuvel LP, Cruysberg JR, Trijbels FJ, Blom HJ. The molecular basis of cystathionine β-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment. Am J Hum Genet. 1999;65:59–67. PubMed PMC
Kluijtmans LA, Boers GH, Stevens EM, Renier WO, Kraus JP, Trijbels FJ, van den Heuvel LP, Blom HJ. Defective cystathionine β-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J Clin Invest. 1996;98:285–289. PubMed PMC
Kopecka J, Krijt J, Rakova K, Kozich V. Restoring assembly and activity of cystathionine β-synthase mutants by ligands and chemical chaperones. J Inherit Metab Dis. In press. DOI: 10.1007/s10545-010-9087-5. PubMed DOI PMC
Kozich V, de Franchis R, Kraus JP. Molecular defect in a patient with pyridoxine-responsive homocystinuria. Hum Mol Genet. 1993;2:815–816. PubMed
Kozich V, Kraus JP. Screening for mutations by expressing patient cDNA segments in E. coli: homocystinuria due to cystathionine β-synthase deficiency. Hum Mutat. 1992;1:113–123. PubMed
Kruger WD, Wang L, Jhee KH, Singh RH, Elsas LJ., 2nd Cystathionine β-synthase deficiency in Georgia: correlation of clinical and biochemical phenotype with genotype. Hum Mutat. 2003;22:434–441. PubMed
Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685. PubMed
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193:265–275. PubMed
Maclean KN, Gaustadnes M, Oliveriusova J, Janosik M, Kraus E, Kozich V, Kery V, Skovby F, Rudiger N, Ingerslev J. High homocysteine and thrombosis without connective tissue disorders are associated with a novel class of cystathionine β-synthase (CBS) mutations. Hum Mutat. 2002;19:641–655. PubMed
Marble M, Geraghty MT, de Franchis R, Kraus JP, Valle D. Characterization of a cystathionine β-synthase allele with three mutations in cis in a patient with B6 nonresponsive homocystinuria. Hum Mol Genet. 1994;3:1883–1886. PubMed
Mato JM, Avila MA, Corrales FJ. Biosynthesis of S-adenosylmethionin. In: Carmel R, Jacobsen DW, editors. Homocysteine in health and disease. Cambridge: Cambridge University Press; 2001. pp. 47–62.
Meier M, Janosik M, Kery V, Kraus JP, Burkhard P. Structure of human cystathionine β-synthase: a unique pyridoxal 5′-phosphate-dependent heme protein. EMBO J. 2001;20:3910–3916. PubMed PMC
Meier M, Oliveriusova J, Kraus JP, Burkhard P. Structural insights into mutations of cystathionine β-synthase. Biochim Biophys Acta. 2003;1647:206–213. PubMed
Mirkovic N, Marti-Renom MA, Weber BL, Sali A, Monteiro AN. Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition. Cancer Res. 2004;64:3790–3797. PubMed
Mudd SH, Levy HL, Kraus JP. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 8th ed. New York: McGraw-Hill; 2001. pp. 2007–2056.
Ojha S, Wu J, LoBrutto R, Banerjee R. Effects of heme ligand mutations including a pathogenic variant, H65R, on the properties of human cystathionine β-synthase. Biochemistry. 2002;41:4649–4654. PubMed
Orendac M, Pronicka E, Kubalska J, Janosik M, Sokolova J, Linnebank M, Koch HG, Kozich V. Identification and functional analysis of two novel mutations in the CBS gene in Polish patients with homocystinuria. Hum Mutat. 2004;23:631. PubMed
Orendac M, Zeman J, Stabler SP, Allen RH, Kraus JP, Bodamer O, Stockler-Ipsiroglu S, Kvasnicka J, Kozich V. Homocystinuria due to cystathionine β-synthase deficiency: novel biochemical findings and treatment efficacy. J Inherit Metab Dis. 2003;26:761–773. PubMed
Proudfoot M, Sanders SA, Singer A, Zhang R, Brown G, Binkowski A, Xu L, Lukin JA, Murzin AG, Joachimiak A. Biochemical and structural characterization of a novel family of cystathionine β-synthase domain proteins fused to a Zn ribbon-like domain. J Mol Biol. 2008;375:301–315. PubMed PMC
Refsum H, Fredriksen A, Meyer K, Ueland PM, Kase BF. Birth prevalence of homocystinuria. J Pediatr. 2004;144:830–832. PubMed
Sali A, Blundell TL. Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol. 1993;234:779–815. PubMed
Sali A, Overington JP. Derivation of rules for comparative protein modeling from a database of protein structure alignments. Protein Sci. 1994;3:1582–1596. PubMed PMC
Sebastio G, Sperandeo MP, Panico M, de Franchis R, Kraus JP, Andria G. The molecular basis of homocystinuria due to cystathionine β-synthase deficiency in Italian families, and report of four novel mutations. Am J Hum Genet. 1995;56:1324–1333. PubMed PMC
Sen S, Yu J, Yamanishi M, Schellhorn D, Banerjee R. Mapping peptides correlated with transmission of intrasteric inhibition and allosteric activation in human cystathionine β-synthase. Biochemistry. 2005;44:14210–14216. PubMed
Shan X, Dunbrack RL, Jr, Christopher SA, Kruger WD. Mutations in the regulatory domain of cystathionine β synthase can functionally suppress patient-derived mutations in cis. Hum Mol Genet. 2001;10:635–643. PubMed
Singh LR, Chen X, Kozich V, Kruger WD. Chemical chaperone rescue of mutant human cystathionine β-synthase. Mol Genet Metab. 2007;91:335–342. PubMed PMC
Urreizti R, Asteggiano C, Cozar M, Frank N, Vilaseca MA, Grinberg D, Balcells S. Functional assays testing pathogenicity of 14 cystathionine-β synthase mutations. Hum Mutat. 2006;27:211. PubMed
Wang L, Chen X, Tang B, Hua X, Klein-Szanto A, Kruger WD. Expression of mutant human cystathionine β-synthase rescues neonatal lethality but not homocystinuria in a mouse model. Hum Mol Genet. 2005;14:2201–2208. PubMed PMC
Waters PJ. How PAH gene mutations cause hyper-phenylalaninemia and why mechanism matters: insights from in vitro expression. Hum Mutat. 2003;21:357–369. PubMed
Yamanishi M, Kabil O, Sen S, Banerjee R. Structural insights into pathogenic mutations in heme-dependent cystathionine-β-synthase. J Inorg Biochem. 2006;100:1988–1995. PubMed
Recent therapeutic approaches to cystathionine beta-synthase-deficient homocystinuria
A proactive genotype-to-patient-phenotype map for cystathionine beta-synthase
Chaperone therapy for homocystinuria: the rescue of CBS mutations by heme arginate
Conformational properties of nine purified cystathionine β-synthase mutants